Enhanced Recovery After Surgery Impact on the Systemic Inflammatory Response of Patients Following Gynecological Oncology Surgery: A Prospective Randomized Study

References

• Gibb A, Crosby MA, McDiarmid C, et al. Creation of an Enhanced Recovery After Surgery (ERAS) Guideline for neonatal intestinal surgery patients: a knowledge synthesis and consensus generation approach and protocol study. BMJ Open. 2018;8(12):e023651. doi:10.1136/bmjopen-2018-023651
   PubMed Web of Science ®Google Scholar
• Gustafsson UO, Scott MJ, Hubner M, et al. Guidelines for perioperative care in elective colorectal surgery: enhanced recovery after surgery (ERAS®) Society Recommendations: 2018. World J Surg. 2019;43(3):659–695.30426190
   PubMed Web of Science ®Google Scholar
• Batchelor T, Rasburn NJ, Abdelnour-Berchtold E, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg. 2019;55(1):91–115.30304509
   PubMed Web of Science ®Google Scholar
• Nelson G, Bakkum-Gamez J, Kalogera E, et al. Guidelines for perioperative care in gynecologic/oncology: enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer. 2019;29(4):651–668. doi:10.1136/ijgc-2019-00035630877144
   PubMed Web of Science ®Google Scholar
• Melloul E, Hübner M, Scott M, et al. Guidelines for perioperative care for liver surgery: enhanced Recovery After Surgery (ERAS) Society Recommendations. World J Surg. 2016;40(10):2425–2440. doi:10.1007/s00268-016-3700-127549599
   PubMed Web of Science ®Google Scholar
• Low DE, Allum W, De Manzoni G, et al. Guidelines for Perioperative Care in Esophagectomy: enhanced Recovery After Surgery (ERAS®) Society Recommendations. World J Surg. 2019;43(2):299–330.30276441
   PubMed Web of Science ®Google Scholar
• Temple-Oberle C, Shea-Budgell MA, Tan M, et al. Consensus Review of Optimal Perioperative Care in Breast Reconstruction: enhanced Recovery after Surgery (ERAS) Society Recommendations. Plast Reconstr Surg. 2017;139(5):1056e–1071e. doi:10.1097/PRS.0000000000003242
   PubMed Web of Science ®Google Scholar
• Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg. 2017;152(3):292–298. doi:10.1001/jamasurg.2016.495228097305
   PubMed Web of Science ®Google Scholar
• Rogers LJ, Bleetman D, Messenger DE, et al. The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer. J Thorac Cardiovasc Surg. 2018;155(4):1843–1852. doi:10.1016/j.jtcvs.2017.10.15129352586
   PubMed Web of Science ®Google Scholar
• Bisch SP, Wells T, Gramlich L, et al. Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: system-wide implementation and audit leads to improved value and patient outcomes. Gynecol Oncol. 2018;151(1):117–123. doi:10.1016/j.ygyno.2018.08.00730100053
   PubMed Web of Science ®Google Scholar
• Parise P, Ferrari C, Cossu A, et al. Enhanced Recovery After Surgery (ERAS) pathway in esophagectomy: is a reasonable prediction of hospital stay possible. Ann Surg. 2019;270(1):77–83. doi:10.1097/SLA.000000000000277529672400
   PubMed Web of Science ®Google Scholar
• Arrick L, Mayson K, Hong T, Warnock G. Enhanced recovery after surgery in colorectal surgery: impact of protocol adherence on patient outcomes. J Clin Anesth. 2019;55:7–12. doi:10.1016/j.jclinane.2018.12.03430583114
   PubMed Web of Science ®Google Scholar
• Committee on Gynecologic Practice. ACOG Committee Opinion No. 750: perioperative pathways: enhanced recovery after surgery. Obstet Gynecol. 2018;132(3):e120–e130. doi:10.1097/AOG.000000000000281830134426
   PubMed Web of Science ®Google Scholar
• Ferrari F, Forte S, Sbalzer N, et al. Validation of an enhanced recovery after surgery protocol in gynecologic surgery: an Italian randomized study. Am J Obstet Gynecol. 2020;223(4):543.e1–543.e14. doi:10.1016/j.ajog.2020.07.003
   PubMed Web of Science ®Google Scholar
• Gramlich LM, Sheppard CE, Wasylak T, et al. Implementation of Enhanced Recovery After Surgery: a strategy to transform surgical care across a health system. Implement Sci. 2017;12(1):67. doi:10.1186/s13012-017-0597-528526041
   PubMed Web of Science ®Google Scholar
• Deng Y, Zhu J, Liu Z, Huang M, Chang DW, Gu J. Elevated systemic inflammatory responses, factors associated with physical and mental quality of life, and prognosis of hepatocellular carcinoma. Aging (Albany NY). 2020;12(5):4357–4370. doi:10.18632/aging.10288932145060
   PubMedGoogle Scholar
• Dolan RD, McSorley ST, Horgan PG, Laird B, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol. 2017;116:134–146. doi:10.1016/j.critrevonc.2017.06.00228693795
   PubMed Web of Science ®Google Scholar
• Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis. Sci Rep. 2017;7(1):16717.29196718
   PubMed Web of Science ®Google Scholar
• Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124. doi:10.1093/jnci/dju12424875653
   PubMedGoogle Scholar
• Li B, Zhou P, Liu Y, et al. Platelet-to-lymphocyte ratio in advanced Cancer: review and meta-analysis. Clin Chim Acta. 2018;483:48–56. doi:10.1016/j.cca.2018.04.02329678631
   PubMed Web of Science ®Google Scholar
• Yodying H, Matsuda A, Miyashita M, et al. Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2016;23(2):646–654. doi:10.1245/s10434-015-4869-526416715
   PubMed Web of Science ®Google Scholar
• Haram A, Boland MR, Kelly ME, Bolger JC, Waldron RM, Kerin MJ. The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review. J Surg Oncol. 2017;115(4):470–479. doi:10.1002/jso.2452328105646
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhao X, Lu J, Xue J, Liu P, Mao H. Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies. Arch Gynecol Obstet. 2018;297(4):849–857. doi:10.1007/s00404-018-4678-829368160
   PubMed Web of Science ®Google Scholar
• Diem S, Schmid S, Krapf M, et al. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer. 2017;111:176–181. doi:10.1016/j.lungcan.2017.07.02428838390
   PubMed Web of Science ®Google Scholar
• Dupré A, Malik HZ. Inflammation and cancer: what a surgical oncologist should know. Eur J Surg Oncol. 2018;44(5):566–570. doi:10.1016/j.ejso.2018.02.20929530345
   PubMed Web of Science ®Google Scholar
• Lattanzi S, Brigo F, Trinka E, Cagnetti C, Di Napoli M, Silvestrini M. Neutrophil-to-lymphocyte ratio in acute cerebral hemorrhage: a system review. Transl Stroke Res. 2019;10(2):137–145. doi:10.1007/s12975-018-0649-430090954
   PubMed Web of Science ®Google Scholar
• Stawicki SP, Kalra S, Jones C, et al. Comorbidity polypharmacy score and its clinical utility: a pragmatic practitioner’s perspective. J Emerg Trauma Shock. 2015;8(4):224–231. doi:10.4103/0974-2700.16165826604529
   PubMedGoogle Scholar
• Agha R, Abdall-Razak A, Crossley E, et al. STROCSS 2019 Guideline: strengthening the reporting of cohort studies in surgery. Int J Surg. 2019;72:156–165. doi:10.1016/j.ijsu.2019.11.00231704426
   PubMed Web of Science ®Google Scholar
• Kalogera E, Bakkum-Gamez JN, Jankowski CJ, et al. Enhanced recovery in gynecologic surgery. Obstet Gynecol. 2013;122(2 Pt 1):319–328. doi:10.1097/AOG.0b013e31829aa78023969801
   PubMed Web of Science ®Google Scholar
• Wijk L, Udumyan R, Pache B, et al. International validation of enhanced recovery after surgery society guidelines on enhanced recovery for gynecologic surgery. Am J Obstet Gynecol. 2019;221(3):237.e1–237.e11. doi:10.1016/j.ajog.2019.04.028
   PubMed Web of Science ®Google Scholar
• McLeod RS, Aarts MA, Chung F, et al. Development of an enhanced recovery after surgery guideline and implementation strategy based on the knowledge-to-action cycle. Ann Surg. 2015;262(6):1016–1025. doi:10.1097/SLA.000000000000106725692358
   PubMed Web of Science ®Google Scholar
• Aarts MA, Rotstein OD, Pearsall EA, et al. Postoperative ERAS interventions have the greatest impact on optimal recovery: experience with implementation of ERAS across multiple hospitals. Ann Surg. 2018;267(6):992–997. doi:10.1097/SLA.000000000000263229303803
   PubMed Web of Science ®Google Scholar
• Lord JM, Midwinter MJ, Chen YF, et al. The systemic immune response to trauma: an overview of pathophysiology and treatment. Lancet. 2014;384(9952):1455–1465. doi:10.1016/S0140-6736(14)60687-525390327
   PubMed Web of Science ®Google Scholar
• Zang YF, Li FZ, Ji ZP, Ding YL. Application value of enhanced recovery after surgery for total laparoscopic uncut Roux-en-Y gastrojejunostomy after distal gastrectomy. World J Gastroenterol. 2018;24(4):504–510. doi:10.3748/wjg.v24.i4.50429398871
   PubMed Web of Science ®Google Scholar
• Funk DJ, HayGlass KT, Koulack J, Harding G, Boyd A, Brinkman R. A randomized controlled trial on the effects of goal-directed therapy on the inflammatory response open abdominal aortic aneurysm repair. Crit Care. 2015;19:247. doi:10.1186/s13054-015-0974-x26062689
   PubMed Web of Science ®Google Scholar
• Ren K, Yin Y, He F, Shao Y, Wang S. Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer. Cancer Manag Res. 2018;10:4891–4898. doi:10.2147/CMAR.S18069530425580
   PubMed Web of Science ®Google Scholar
• Tiainen S, Rilla K, Hämäläinen K, Oikari S, Auvinen P. The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype. Breast Cancer Res Treat. 2021;185(1):63–72. doi:10.1007/s10549-020-05925-732948994
   PubMed Web of Science ®Google Scholar
• Cong R, Kong F, Ma J, Li Q, Wu Q, Ma X. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer. BMC Cancer. 2020;20(1):464. doi:10.1186/s12885-020-06953-832448185
   PubMed Web of Science ®Google Scholar